Lung Cancer Considered
Episodes
AACR 2026 Highlights: KRAS Updates
05 May 2026
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses KRAS updates from the American Association for Cancer Research (AACR) 2026 A...
LCC in Spanish: Manejo perioperatorio en cáncer de pulmón en estadio temprano
24 Apr 2026
Contributed by Lukas
This episode of Lung Cancer Considered, part of IASLC’s World Language Series, features host Dr. Narjust Florez leading a Spanish-language discussio...
IASLC - Nursing & Allied Health in Lung Cancer Care and Clinical Research
21 Apr 2026
Contributed by Lukas
This episode of LCC covers the work of our nursing and allied health professional committee and, most importantly, highlight their role in the care of...
IASLC - Lung Cancer Considered India
07 Apr 2026
Contributed by Lukas
This episode of Lung Cancer Considered covers lung cancer in India and brings awareness about its first and largest advocacy group in the nation. To l...
LCC in Korean: A Case-Based Discussion on EGFR-Mutant NSCLC
03 Apr 2026
Contributed by Lukas
As part of IASLC’s ongoing podcast series in world languages, Dr. Chul Kim moderates a discussion in Korean with Dr. Beung-Chul Ahn and Dr. Hyein Je...
IASLC LCC - Early Stage and Preoperative Care for NSCLC and EFGR in Mandarin
20 Mar 2026
Contributed by Lukas
In this episode, recorded in Mandarin, host Dr. Chunxia Su leads a discussion about early stage and preoperative care for patients with NSCLC with an ...
IASLC - TTLC_Molecular Tumor Board
17 Mar 2026
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Narjust Florez conducts three mock molecular tumor boards with Dr. Misako Nagasaka and Dr. Biagio ...
Live from TTLC 2026: ADCs Controversies
10 Mar 2026
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Narjust Florez and guest Dr. Sam Rosner examine controversies around antibody-drug conjugates (AD...
LCC in French_Virtual Tumor Board - EFGR NSCLC (1)
06 Mar 2026
Contributed by Lukas
As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Angela Botti...
Virtual Tumor Board: EGFR-mutant NSCLC
03 Mar 2026
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by Dr. Sara Pilotto and Dr. Jonathan Riess for a virtual tumor board discuss...
Controversies in the Management of Lung Cancer: Comorbidities
27 Feb 2026
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Narjust Florez explores controversies in managing lung cancer patients with comorbidities – thos...
• Live from TTLC 2026: Emerging Molecular Targets in Non-Small Cell Lung Cancer (NSCLC)
24 Feb 2026
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Narjust Florez explores the evolving landscape of emerging molecular targets in NSCLC with Dr. Kel...
Virtual Tumor Board: Current Treatment for Small Cell Lung Cancer (SCLC)
17 Feb 2026
Contributed by Lukas
This episode of Lung Cancer Considered focuses on a case of a patient with extensive stage SCLC. SCLC is a highly lethal subtype of lung cancer, accou...
IASLC Global Policy Update
17 Feb 2026
Contributed by Lukas
This episode examines the role public policy plays in impacting lung cancer treatment and research. The world has made tremendous progress in the tre...
• LCC in Cantonese: Updates in Surgical Approaches and Techniques in Early-Stage Lung Cancer
13 Feb 2026
Contributed by Lukas
As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with two e...
Lung Cancer Considered: AI and Patient Care
10 Feb 2026
Contributed by Lukas
This episode of Lung Cancer Considered examines how artificial intelligence is being incorporated into patient care and what the future holds for this...
Lung Cancer Considered: Lung Cancer Care in Areas of Conflict and War
03 Feb 2026
Contributed by Lukas
This episode of Lung Cancer Considered, hosted by Dr. Narjust Florez, examines the challenges of delivering lung cancer care in areas affected by war ...
LCC in Turkish: Virtual Tumor Board Immunotherapy for NSCLC
30 Jan 2026
Contributed by Lukas
As part of IASLC’s ongoing series of Lung Cancer Considered podcast episodes in world languages, Dr. Ece Cali moderates a discussion in Turkish with...
Lung Cancer Considered: IASLC Hot Topic in Basic & Translational Science Meeting Highlights
20 Jan 2026
Contributed by Lukas
This episode reviews the IASLC 2025 Hot Topic in Basic and Translational Science Conference, which focused on unraveling precancer and early-stage lun...
Lung Cancer Considered in Portuguese: Junior Faculty Perspective
16 Jan 2026
Contributed by Lukas
As part of IASLC’s Lung Cancer Considered World Language Series, guest host Dr. Maria Cecilia Mathias leads a discussion in Portuguese about the jun...
Lung Cancer Considered: Role of General Media in Lung Cancer Research
06 Jan 2026
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by CNN Medical Correspondent Meg Tirrell and WTOP reporter Neal Augenstein t...
Lung Cancer Considered -- Immunotherapy Toxicity: Myths & Pearls
30 Dec 2025
Contributed by Lukas
Since the first immunotherapy agent for lung cancer was approved in 2015, this class of drugs has captured the imagination and the narrative for the t...
Lung Cancer Considered: A New Shot at Progress: Amivantamab Goes SubQ
23 Dec 2025
Contributed by Lukas
The FDA has approved subcutaneous amivantamab. Join host Dr. Narjust Florez and guests, Dr. Natasha Leighl and Dr. Federico Cappuzzo, as they explore...
Lung Cancer Considered at the ASCO IASLC 2025 North American Conference on Lung Cancer
16 Dec 2025
Contributed by Lukas
In this special episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu discuss highlights from the IASLC | ASCO 2025 North America ...
Lung Cancer Care in New Zealand
09 Dec 2025
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with two thoracic oncologists practicing in New Zealand—Dr. Laird Cameron fro...
LCC in Spanish: Mujeres and oncologia toracica – Latinoamerica
05 Dec 2025
Contributed by Lukas
As part of IASLC’s Lung Cancer Considered World Language Series, host Dr. Narjust Florez leads a Spanish-language discussion with three leaders in t...
IASLC Lung Cancer Considered: ADCs in EGFR Mutant NSCLC
02 Dec 2025
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with Prof. Li Zhang and Dr. Elaine Shum about recent progress in antibody–dru...
Can I Take That? Integrative Medicine and Lung Cancer
18 Nov 2025
Contributed by Lukas
Join Dr. Narjust Florez as she explores complementary and integrative medicine in lung cancer care with leading experts Dr. Ting Bao, Dr. Jun J. Mao, ...
LCC in Spanish: ¿Pulmón Vital: donde la ciencia se encuentra con la medicina tradicional
14 Nov 2025
Contributed by Lukas
As part of IASLC’s Lung Cancer Considered world language series, host Dr. Narjust Florez discusses the role of complementary medicine in cancer care...
LCC in Georgian: WCLC 2025 Highlights
07 Nov 2025
Contributed by Lukas
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung can...
The New Face of Lung Cancer: A Conversation with Two Young Lung Cancer Warriors
04 Nov 2025
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Narjust Florez speaks with two remarkable young lung cancer advocates Samantha Murell and Megan Fl...
LCC in Hungarian: WCLC 2025 Highlights
31 Oct 2025
Contributed by Lukas
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung can...
IASLC Lung Cancer Considered: ESMO 2025 Highlights
28 Oct 2025
Contributed by Lukas
This episode of Lung Cancer Considered covers highlights from the 2025 ESMO Annual Meeting held October 17th to the 21st in Berlin, Germany. Guests ...
Lung Cancer Considered: • Rising Above: The Lung Cancer Hope Summit
21 Oct 2025
Contributed by Lukas
In this episode of Lung Cancer Considered, Dr. Narjust Florez leads a discussion with Ann Fish-Steagall and Amanda Nerstad about the 2025 Lung Cancer ...
LCC in Greek: WCLC 2025 Highlights
10 Oct 2025
Contributed by Lukas
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung can...
FDA Approval: Maintenance Lurbinectedin for SCLC
07 Oct 2025
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of maintenance lurbinectedin plus atezolizumab for e...
LCC in Arabic: WCLC 2025 Highlights
03 Oct 2025
Contributed by Lukas
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung can...
Lung Cancer Considered in Dutch: Targeting EGFR NSCLC
03 Oct 2025
Contributed by Lukas
As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Lizza Hendriks moderates a discussion in Dutch with Dr....
Lung Cancer Considered: Targeting EGFR NSCLC
03 Oct 2025
Contributed by Lukas
Lung Cancer Considered: Targeting EGFR NSCLC by IASLC
Lung Cancer Considered in Japanese---2025 WCLC Highlights
02 Oct 2025
Contributed by Lukas
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung can...
LCC in Korean: WCLC 2025 Highlights
30 Sep 2025
Contributed by Lukas
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung can...
IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy
26 Sep 2025
Contributed by Lukas
This episode of Lung Cancer Considered reviews new and upcoming approvals for subcutaneous immune checkpoint inhibitors. Join host Dr. Narjust Florez ...
LCC in Mandarin: WCLC 2025 Highlights with Experts from Taiwan
18 Sep 2025
Contributed by Lukas
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung can...
LCC in Portuguese: WCLC 2025 Highlights
16 Sep 2025
Contributed by Lukas
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung can...
LCC in Spanish: WCLC 2025 Through a Junior Faculty Lens
11 Sep 2025
Contributed by Lukas
In this episode, recorded live in Spanish at WCLC 2025, Dr. Diego Carrillo reflects on his experiences as a junior faculty member at WCLC 2025. In co...
LCC in Hebrew: WCLC 2025 Highlights
10 Sep 2025
Contributed by Lukas
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung can...
Live From WCLC 2025: Tuesday Highlights & Meeting Summary
09 Sep 2025
Contributed by Lukas
In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss highlights from the conference. Dr...
LCC in Spanish: WCLC 2025 Highlights
09 Sep 2025
Contributed by Lukas
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung can...
Live From WCLC 2025: Monday Highlights
08 Sep 2025
Contributed by Lukas
In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference...
LCC in Mandarin: WCLC 2025 Highlights
08 Sep 2025
Contributed by Lukas
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung can...
Live From WCLC 2025: Sunday Highlights
07 Sep 2025
Contributed by Lukas
In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference...
"I'm in Barcelona, Now What?" — Tips for First-Time WCLC Attendees
06 Sep 2025
Contributed by Lukas
In this episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu share tips for first-time attendees of the World Conference on Lung ...
LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC
29 Aug 2025
Contributed by Lukas
LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC by IASLC
IASLC - ALK Positive Summit
26 Aug 2025
Contributed by Lukas
IASLC - ALK Positive Summit by IASLC
LCC in Greek: Virtual Tumor Board - ALK NSCLC
22 Aug 2025
Contributed by Lukas
LCC in Greek: Virtual Tumor Board - ALK NSCLC by IASLC
Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy
19 Aug 2025
Contributed by Lukas
Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy by IASLC
LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer
15 Aug 2025
Contributed by Lukas
LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer by IASLC
FDA Approval: Zongertinib for HER2 Mutant NSCLC
12 Aug 2025
Contributed by Lukas
FDA Approval: Zongertinib for HER2 Mutant NSCLC by IASLC
LCC in Arabic: Arab Women's Voices in Thoracic Oncology
08 Aug 2025
Contributed by Lukas
As part of IASLC’s ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Asrar AlAhmadi and...
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions
05 Aug 2025
Contributed by Lukas
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions
05 Aug 2025
Contributed by Lukas
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC
LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania
02 Aug 2025
Contributed by Lukas
LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania by IASLC
IASLC - Stigma
29 Jul 2025
Contributed by Lukas
IASLC - Stigma by IASLC
LCC in Japanese: ASCO 2025 Highlights
25 Jul 2025
Contributed by Lukas
LCC in Japanese: ASCO 2025 Highlights by IASLC
Preview: IASLC | ASCO 2025 North American Conference on Lung Cancer
23 Jul 2025
Contributed by Lukas
On December 5, 2025, we will kick off the IASLC ASCO 2025 North America Conference on Lung Cancer. Guest include Dr. Ramesh Rengan, the Peter Wootton...
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC
18 Jul 2025
Contributed by Lukas
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC
FDA Approval: Sunvozertinib for EGFR Exon 20
15 Jul 2025
Contributed by Lukas
FDA Approval: Sunvozertinib for EGFR Exon 20 by IASLC
LCC in Portuguese: Virtual Tumor Board - EGFR NSCLC
11 Jul 2025
Contributed by Lukas
LCC in Portuguese: Virtual Tumor Board - EGFR NSCLC by IASLC
IASLC_WCLC 2025 Preview
08 Jul 2025
Contributed by Lukas
IASLC_WCLC 2025 Preview by IASLC
Virtual Tumor Board: Resectable EGFR NSCLC
01 Jul 2025
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case with Dr. Chunxia Su and Dr. Collin Blakely. The c...
FDA Approval: Taletrectinib and ROS1 NSCLC
24 Jun 2025
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of taletrectinib, a next-generation ROS1 kinase inhi...
IASLC - ASCO 2025 Highlights
06 Jun 2025
Contributed by Lukas
ASCO 2025 Highlights Guests: Charu Aggarwal, MD, MPH Leslye M. Heisler Professor of Medicine Section Chief, Thoracic and Head & Neck Cancer Associat...
FDA Approval: Telisotuzumab Vedotin and MET-Positive NSCLC
27 May 2025
Contributed by Lukas
In this episode, we will discuss the FDA approval of telisotuzumab vedotin, an antibody drug conjugate, for NSCLC with high c-MET expression. To help ...
LCC in Korean: Lung Cancer Updates & Future Directions
23 May 2025
Contributed by Lukas
LCC in Korean: Lung Cancer Updates & Future Directions by IASLC
Global Advances and Persistent Disparities in Lung Cancer Treatment
20 May 2025
Contributed by Lukas
Global Advances and Persistent Disparities in Lung Cancer Treatment by IASLC
Dr. Bryant Lin Teaching My Cancer
06 May 2025
Contributed by Lukas
Dr. Bryant Lin Teaching My Cancer by IASLC
AACR 2025 Highlights
02 May 2025
Contributed by Lukas
AACR 2025 Highlights by IASLC
What You Should Know About RET-Positive NSCLC: Live from TexasLung25
29 Apr 2025
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Mihaela Alde...
Excuse me, What? Top Recommendations for Effective Patient Communication: Live from TexasLung25
22 Apr 2025
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Eric Singhi ...
ELCC 2025 Highlights: Insights and Review of the Data
05 Apr 2025
Contributed by Lukas
Guest: Dr. Corey Langer is the Director of Thoracic Oncology and Professor of Medicine at the Hospital of the University of Pennsylvania
LCC in Korean: 2024 Lung Cancer Updates
16 Mar 2025
Contributed by Lukas
LCC in Korean: 2024 Lung Cancer Updates by IASLC
Virtual Tumor Board: Targeting Residual Disease
16 Mar 2025
Contributed by Lukas
Virtual Tumor Board: Targeting Residual Disease by IASLC
LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC
16 Mar 2025
Contributed by Lukas
LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC by IASLC
LCC in Italian: Virtual Tumor Board - Resectable NSCLC
16 Mar 2025
Contributed by Lukas
LCC in Italian: Virtual Tumor Board - Resectable NSCLC by IASLC
The Microbiome and Immunotherapy for Lung Cancer
16 Mar 2025
Contributed by Lukas
The Microbiome and Immunotherapy for Lung Cancer by IASLC
Live from TTLC25: Lung Cancer and Brain Metastasis
15 Mar 2025
Contributed by Lukas
Live from TTLC25: Lung Cancer and Brain Metastasis by IASLC
Thymus Talk: Unraveling Thymoma and Thymic Carcinoma
15 Mar 2025
Contributed by Lukas
This episode of Lung Cancer Considered takes an in-depth look at thymoma and thymic carcinomas, both challenging diseases to treat with evolving new t...
Lung Cancer Considered in Turkish: First-Line Therapies in EGFR Mutant NSCLC
15 Mar 2025
Contributed by Lukas
Host: Ece Cali Daylan, Assistant Professor of Medicine, Division of Oncology at Washington University School of Medicine Guest: Saadettin Kilickap G...
Lung Cancer Considered in Hungarian: Lung Cancer Treatment Updates
14 Mar 2025
Contributed by Lukas
As part of IASLC's ongoing series of podcasts in world languages, Dr. Balazs Halmos moderates a discussion in Hungarian with Dr. Krisztina Bogos, Dr. ...
LCC in Cantonese: WCLC24 Highlights
09 Mar 2025
Contributed by Lukas
The 2024 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung ca...
Virtual Tumor Board: Stage III ALK+ NSCLC
05 Mar 2025
Contributed by Lukas
Virtual Tumor Board: Stage III ALK+ NSCLC by IASLC
Live from TTLC25: Targeted Therapy in Early Stage NSCLC Debate
28 Feb 2025
Contributed by Lukas
Live from TTLC25: Targeted Therapy in Early Stage NSCLC Debate by IASLC
The Benefits of Patient Advocacy Groups
24 Feb 2025
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Narjust Florez engages in a discussion with patient advocate Summer Farmen. Listen to the episode ...
Live from TTLC25: Targeted Therapy in SCLC
20 Feb 2025
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion on how small cell lung cancer continues to evolve with new treat...
Live from TTLC 2025: Mesothelioma and NUT Carcinoma
20 Feb 2025
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion of two of the most challenging thoracic malignancies – NUT car...
LCC in Arabic: Chemo Immunotherapy in Metastatic NSCLC
14 Feb 2025
Contributed by Lukas
Descriptions: As part of the IASLC's ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Ba...
Virtual Tumor Board: Treating EGFR NSCLC After TKI Resistance
11 Feb 2025
Contributed by Lukas
In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case involving drug resistance in EGFR mutant NSCLC. ...
LAURA Study (Part 2) - Radiation Oncology Perspective
04 Feb 2025
Contributed by Lukas
This episode of Lung Cancer Considered covers the recent FDA approval of Osimertinib after chemo-radiation in EGFR positive NSCLC based on the LAURA t...
Lung Cancer in Mexico: Perspectives from the North and Ciudad de Mexico
27 Jan 2025
Contributed by Lukas
En este episodio de Lung Cancer Considered, vamos a hablar sobre el cancer de pulmón en México. Tengo el placer de tener en este episodio dos docto...
IASLC Lung Cancer Considered in German
22 Jan 2025
Contributed by Lukas
Description: As part of IASLC’s commitment to communicating in all world languages, this episode of Lung Cancer Considered is recorded in German and...